亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes

医学 糖化血红素 格列美脲 二甲双胍 内科学 2型糖尿病 血糖性 糖尿病 甘精胰岛素 内分泌学 格列齐特 利拉鲁肽 磺酰脲 胰岛素
作者
David G. Nathan,John M. Lachin,Ashok Balasubramanyam,Henry B Burch,John B. Buse,Nicole M. Butera,Robert M Cohen,Jill P Crandall,Steven E Kahn,Heidi Krause-Steinrauf,Mary Larkin,Neda Rasouli,Margaret Tiktin,Deborah J Wexler,Naji Younes
出处
期刊:The New England Journal of Medicine [New England Journal of Medicine]
卷期号:387 (12): 1063-1074 被引量:25
标识
DOI:10.1056/nejmoa2200433
摘要

The comparative effectiveness of glucose-lowering medications for use with metformin to maintain target glycated hemoglobin levels in persons with type 2 diabetes is uncertain.In this trial involving participants with type 2 diabetes of less than 10 years' duration who were receiving metformin and had glycated hemoglobin levels of 6.8 to 8.5%, we compared the effectiveness of four commonly used glucose-lowering medications. We randomly assigned participants to receive insulin glargine U-100 (hereafter, glargine), the sulfonylurea glimepiride, the glucagon-like peptide-1 receptor agonist liraglutide, or sitagliptin, a dipeptidyl peptidase 4 inhibitor. The primary metabolic outcome was a glycated hemoglobin level, measured quarterly, of 7.0% or higher that was subsequently confirmed, and the secondary metabolic outcome was a confirmed glycated hemoglobin level greater than 7.5%.A total of 5047 participants (19.8% Black and 18.6% Hispanic or Latinx) who had received metformin for type 2 diabetes were followed for a mean of 5.0 years. The cumulative incidence of a glycated hemoglobin level of 7.0% or higher (the primary metabolic outcome) differed significantly among the four groups (P<0.001 for a global test of differences across groups); the rates with glargine (26.5 per 100 participant-years) and liraglutide (26.1) were similar and lower than those with glimepiride (30.4) and sitagliptin (38.1). The differences among the groups with respect to a glycated hemoglobin level greater than 7.5% (the secondary outcome) paralleled those of the primary outcome. There were no material differences with respect to the primary outcome across prespecified subgroups defined according to sex, age, or race or ethnic group; however, among participants with higher baseline glycated hemoglobin levels there appeared to be an even greater benefit with glargine, liraglutide, and glimepiride than with sitagliptin. Severe hypoglycemia was rare but significantly more frequent with glimepiride (in 2.2% of the participants) than with glargine (1.3%), liraglutide (1.0%), or sitagliptin (0.7%). Participants who received liraglutide reported more frequent gastrointestinal side effects and lost more weight than those in the other treatment groups.All four medications, when added to metformin, decreased glycated hemoglobin levels. However, glargine and liraglutide were significantly, albeit modestly, more effective in achieving and maintaining target glycated hemoglobin levels. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; GRADE ClinicalTrials.gov number, NCT01794143.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
不许焦绿o完成签到,获得积分10
1秒前
开朗紫蓝完成签到,获得积分10
3秒前
4秒前
4秒前
7秒前
8秒前
自然的茉莉完成签到,获得积分10
8秒前
牛角面包发布了新的文献求助10
8秒前
HU完成签到 ,获得积分10
9秒前
科研通AI2S应助吴彦祖采纳,获得10
9秒前
淞33发布了新的文献求助10
10秒前
Mingyue123完成签到,获得积分10
13秒前
科研小白发布了新的文献求助10
14秒前
bkagyin应助不许焦绿o采纳,获得10
15秒前
18秒前
淞33完成签到,获得积分10
20秒前
tgytgy发布了新的文献求助10
23秒前
xinxin完成签到,获得积分10
28秒前
orixero应助吴彦祖采纳,获得10
46秒前
55秒前
yun发布了新的文献求助10
55秒前
59秒前
1分钟前
胖胖猪完成签到,获得积分10
1分钟前
科研通AI2S应助葛力采纳,获得10
1分钟前
Owen应助科研通管家采纳,获得10
1分钟前
1分钟前
科研小白完成签到,获得积分10
1分钟前
jianghs完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
雪白秋柔完成签到 ,获得积分10
1分钟前
lin完成签到,获得积分10
1分钟前
1分钟前
桐桐应助Zoe采纳,获得10
1分钟前
田様应助吴彦祖采纳,获得10
1分钟前
咖啡续命发布了新的文献求助10
2分钟前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Semiconductor Process Reliability in Practice 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 600
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3234546
求助须知:如何正确求助?哪些是违规求助? 2880887
关于积分的说明 8217265
捐赠科研通 2548495
什么是DOI,文献DOI怎么找? 1377786
科研通“疑难数据库(出版商)”最低求助积分说明 647999
邀请新用户注册赠送积分活动 623314